Low-dose Rituximab Monotherapy or in Combination with Tacrolimus Is Effective in Primary Membranous Nephropathy

被引：3
|
作者：
Pathak, Vivek [1 ]
Venkatesan, Madhav [1 ]
Regunathan-Shenk, Renu [1 ,2 ]
机构：
[1] Kovai Med Ctr & Hosp, Nephrol, Coimbatore 641014, Tamil Nadu, India
[2] George Washington Univ, Sch Med & Hlth Sci, Washington, DC 20052 USA
来源：
KIDNEY360 | 2021年 / 2卷 / 02期
关键词：
clinical nephrology; cyclosporine; membranous glomerulonephritis; remission induction; rituximab; tacrolimus;
D O I：
10.34067/KID.0004672020
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：336 / 338
页数：3
相关论文
共 50 条
  • [31] Combination therapy of low-dose cyclosporine and steroid in adults with IgA nephropathy
    Ihm, Hyung-seok
    Lee, Ji-young
    Hwang, Hyun-seok
    Kim, Yang-gyoon
    Moon, Ju-young
    Lee, Sang-ho
    Jeong, Kyung-hwan
    Lee, Tae-won
    Ihm, Chun-gyoo
    CLINICAL NEPHROLOGY, 2019, 92 (03) : 131 - 140
  • [32] Multitarget Combination Immunosuppressive Therapy for Primary Membranous Nephropathy
    Idrees, Najia
    Beck, Laurence H., Jr.
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2021, 78 (06) : 774 - 776
  • [33] Tacrolimus-induced epilepsy with primary membranous nephropathy A case report
    Yang, Yan
    Zhang, Lei
    Mo, Ying
    Ren, Rong
    Wang, Fengmei
    MEDICINE, 2021, 100 (09) : E24989
  • [34] Efficacy analysis of rituximab in treating patients with primary membranous nephropathy dependent on calcineurin inhibitors
    Li, Zhuo
    Zhao, Tingting
    Zhang, Shasha
    Huang, Jing
    Wang, Honggang
    Sun, Yujiao
    Wang, Rong
    Chen, Bing
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [35] Rituximab and low-dose cyclosporine combination therapy for steroid-resistant focal segmental glomerulosclerosis
    Suyama, Kazuhide
    Kawasaki, Yukihiko
    Miyazaki, Kyohei
    Kanno, Syuto
    Ono, Atsushi
    Suzuki, Yuichi
    Ohara, Shinichiro
    Hosoya, Mitsuaki
    PEDIATRICS INTERNATIONAL, 2016, 58 (03) : 219 - 223
  • [36] Effects of Low-Dose Rituximab Therapy in Patients With Primary Cytomegalovirus Infection
    Ishihara, Hiroki
    Ishida, Hideki
    Toki, Daisuke
    Omoto, Kazuya
    Sirakawa, Hiroki
    Shimizu, Tomokazu
    Okumi, Masayoshi
    Tanabe, Kazunari
    EXPERIMENTAL AND CLINICAL TRANSPLANTATION, 2015, 13 (06) : 573 - 580
  • [37] Renal transplantation in children managed with lymphocyte depleting agents and low-dose maintenance tacrolimus monotherapy
    Ellis, Demetrius
    Shapiro, Ron
    Morim, Michael
    Vats, Abhay
    Basu, Amit
    Tan, Henkie
    Kayler, Liise
    Janosky, Janine
    Starzl, Thomas E.
    TRANSPLANTATION, 2007, 83 (12) : 1563 - 1570
  • [38] Efficacy of low-dose rituximab in combination with recombinant human thrombopoietin in treating ITP
    Li, Y.
    Wang, Y. -Y.
    Fei, H. -R.
    Wang, L.
    Yuan, C. -L.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2015, 19 (09) : 1583 - 1588
  • [39] Rituximab in primary membranous nephropathy: a comparative study of three dosing regimens
    Ramachandran, Raja
    Nayak, Saurabh
    Kumar, Vinod
    Sethi, Jasmine
    Minz, Ranjana
    Kumar, Vivek
    Rathi, Manish
    Kohli, Harbir Singh
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2021, 36 (07) : 1352 - 1354
  • [40] Rituximab in Primary Membranous Nephropathy: First-Line Therapy, Why Not?
    Cravedi, Paolo
    Remuzzi, Giuseppe
    Ruggenenti, Piero
    NEPHRON CLINICAL PRACTICE, 2014, 128 (3-4): : 261 - 269
12345